Showing results (91-100 of 227) with videos related to
Sort By:
Pageof 23
Neuro-Oncology Practice|October 13, 2025
A single-institution study of the natural history of fibroblast growth factor receptor-altered gliomasMaya Viera, Christopher W Mount, Dora Dias-Santagata, et al.Cell Host & Microbe|February 11, 2021
HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responsesKiera L Clayton, Geetha Mylvaganam, Alonso Villasmil-Ocando, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2022
Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated IndividualsKathleen M E Gallagher, Mark B Leick, Rebecca C Larson, et al.Cell Death & Disease|April 13, 2023
Quantifying requirements for mitochondrial apoptosis in CAR T killing of cancer cellsAlexandra L Pourzia, Michael L Olson, Stefanie R Bailey, et al.Journal of Neuro-Oncology|December 18, 2024
Clinical progress in the development of CAR T cells to treat malignant gliomaEric P Grewal, Brian V Nahed, Bob S Carter, et al.Biomaterials|July 28, 2014
Poly(lactic-co-glycolic) acid microspheres encapsulated in Pluronic F-127 prolong hirudin delivery and improve functional recovery from a demyelination lesionDrew L Sellers, Tae Hee Kim, Christopher W Mount, et al.Nature Biotechnology|February 1, 2002
Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BBMarcela V Maus, Anna K Thomas, Debra G B Leonard, et al.Cancer Immunology, Immunotherapy : CII|June 20, 2014
Engineered T cells for cancer therapyCarl H June, Marcela V Maus, Gabriela Plesa, et al.Pharmaceutical Research|June 23, 2010
Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imagingTae Hee Kim, Yongping Chen, Christopher W Mount, et al.Nature Communications|April 9, 2026
Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARsJia Li, Shyambabu Chaurasiya, Guihua Sun, et al.Pageof 23